EORTC study of non-Hodgkin's lymphoma: Phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphoma

R. Somers; Patrice Carde; José Thomas; Umberto Tirelli; J.J. Keunig; Dominique Bron; R. De Bock; C. De Wolf‐Peeters; M. van Glabbeke; Alain Delmer; N. Duez

doi:10.1093/annonc/5.suppl_2.s85

Back to search

EORTC study of non-Hodgkin's lymphoma: Phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphoma

R. Somers, Patrice Carde, José Thomas, Umberto Tirelli, J.J. Keunig

DOI: 10.1093/annonc/5.suppl_2.s85

Annals of Oncology

Data up to Jan 2025

Published1994

Citations25

References3

Fields

Medicine Biology Internal medicine Surgery Gastroenterology

Total Citations Per Year

Abstract

References (3)

Comparison of a Second-Generation Combination Chemotherapeutic Regimen (m-BACOD) with a Standard Regimen (CHOP) for Advanced Diffuse Non-Hodgkin's Lymphoma

1992 • 331 citations

Superiority of second over first generation chemotherapy in a randomized trial for stage III-IV intermediate and high-grade Non-Hodgkin's Lymphoma (NHL): The 1980–1985 EORTC trial

1991 • 39 citations

Treatment of patients with aggressive lymphomas: an overview.

1990 • 24 citations

Cited By (0)

Loading...